Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T15:25:53.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Cytomegalovirus antibody production in renal transplant patients

Published online by Cambridge University Press:  15 May 2009

J. Nagington
J. Nagington
Affiliation:
Public Health Laboratory Service, Tennis Court Road, Cambridge
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sera were examined from 50 patients on the renal transplant unit, Cambridge, for antibody against cytomegalovirus by complement fixation and by immuno-fluorescence for IgG and IgM antibodies.

The incidence of antibody on admission was 84% with a possible further 8% so that nearly all had been infected at some time by CMV.

43 (86%) patients showed evidence of active infection after admission, 39 by serology and four only from the examination of post-mortem material.

Twenty-one patients produced IgM antibody and production was prolonged for years in patients that survived. Antibody production was related both to transplantation and admission to hospital.

The evidence indicated that primary CMV infections were rare, that IgM anti-body production was the result of active infection and that this could be attributed to reactivation without the need to invoke re-infection as the source although this type of patient is both susceptible and exposed to re-infection.

Type
Research Article
Information
Journal of Hygiene , Volume 69 , Issue 4 , December 1971 , pp. 645 - 660
Copyright
Copyright © Cambridge University Press 1971

References

REFERENCES

Andersen, H. K. (1969). Complement-fixing and neutralizing antibodies against cytomegalovirus strain AD 169 in sera from infants with cytomegalovirus infection. Scandinavian Journal of Infectious Diseases 1, 141–4.CrossRefGoogle ScholarPubMed
Andersen, H. K. & Spencer, E. S. (1969). Cytomegalovirus infection among renal allograft recipients. Acta medica scandinavica 186, 7–19.CrossRefGoogle ScholarPubMed
Armstrong, D., Balakrishnan, S. L., Steger, L., Yu, B. & Stenzel, K. H. (1971). Cytomegalovirus infections with viremia following renal transplantation. Archives of Internal Medicine 127, 111–15.CrossRefGoogle ScholarPubMed
Bodey, G. P., Wertlake, P. T., Douglas, G. & Levin, R. H. (1965). Cytomegalic inclusion disease in patients with acute leukemia. Annals of Internal Medicine 62, 899–906.CrossRefGoogle ScholarPubMed
Bradstreet, C. M. P. & Taylor, C. E. D. (1962). Technique of complement-fixation test applicable to the diagnosis of virus diseases. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 21, 96–104.Google Scholar
Carlstrom, G. (1965). Virologic studies on cytomegalic inclusion disease. Acta paediatrica scandinavica 54, 17–23.CrossRefGoogle Scholar
Caul, E. O., Clarke, S. K. R., Mott, M. G., Perham, T. G. M. & Wilson, R. S. E. (1971). Cytomegalovirus infections after open heart surgery. A prospective study. Lancet i, 777–81.CrossRefGoogle Scholar
Craighead, J. E. (1969). Immunologic response to cytomegalovirus infection in renal allograft recipients. American Journal of Epidemiology 90, 506–13.CrossRefGoogle ScholarPubMed
Craighead, J. E., Hanshaw, J. B. & Carpenter, C. B. (1967). Cytomegalovirus infection after renal allotransplantation. Journal of the American Medical Association 201, 725–8.CrossRefGoogle ScholarPubMed
Diosi, P., Moldovan, E. & Tomescu, N. (1969). Latent cytomegalovirus infection in blood donors. British Medical Journal iv, 660–2.CrossRefGoogle Scholar
Dreesman, G. R. & Benyesh-Melnick, M. (1967). Spectrum of cytomegalovirus complement-fixing antigens. Journal of Immunology 99, 1106–14.CrossRefGoogle ScholarPubMed
Hanshaw, J. B., Steinfeld, H. J. & White, Cherie J. (1968). Fluorescent-antibody test for cytomegalovirus macroglobulin. New England Journal of Medicine 279, 566–70.CrossRefGoogle ScholarPubMed
Hedley-Whyte, E. T. & Craighead, J. E. (1965). Generalized cytomegalic inclusion disease after renal homotransplantation. New England Journal of Medicine 272, 473–8.CrossRefGoogle ScholarPubMed
Henle, W., Henle, G., Scriba, M., Joyner, C. R., Harrison, F. S. Jr., Von Essen, R., Paloheimo, J. & Klemola, E. (1970). Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open heart and other surgery. New England Journal of Medicine 282, 1068–74.CrossRefGoogle Scholar
Kääriäinen, L., Klemola, E. & Paloheimo, J. (1966). Rise of cytomegalovirus antibodies in infectious-mononucleosis-like syndrome after transfusion. British Medical Journal i, 1270–2.CrossRefGoogle Scholar
Kanich, R. E. & Craighead, J. E. (1966). Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients. American Journal of Medicine 40, 874–82.CrossRefGoogle ScholarPubMed
Klemola, E., Von Essen, R., Paloheimo, J. & Furuhjelm, U. (1969). Cytomegalovirus antibodies in donors of fresh blood to patients submitted to open-heart surgery. Scandinavian Journal of Infectious Diseases 1, 137–40.CrossRefGoogle ScholarPubMed
Krech, U. & Jung, M. (1969). The development of neutralizing antibodies in guinea-pigs following immunization with human cytomegalovirus. Archiv für die Gesamte Virusforschung 28, 248–50.CrossRefGoogle ScholarPubMed
Lang, D. J. & Hanshaw, J. B. (1969). Cytomegalovirus and the post perfusion syndrome. Recognition of primary infection in four patients. New England Journal of Medicine 280, 1145–9.CrossRefGoogle Scholar
Lang, D. J. & Noren, B. (1968). Cytomegaloviremia following congenital infection. Journal of Pediatrics 73, 812–19.CrossRefGoogle ScholarPubMed
Montgomerie, J. Z., Becroft, D. M. O., Croxon, M. C., Doak, P. B. & North, J. D. K. (1969). Herpes-simplex-virus infection after renal transplantation. Lancet ii, 867–71.CrossRefGoogle Scholar
Paloheimo, J., Von Essen, R., Klemola, E., Kääriäinen, L. & Siltanen, P. (1968). Subclinical cytomegalovirus infection and cytomegalovirus mononucleosis after open-heart surgery. American Journal of Cardiology 22, 624–9.CrossRefGoogle ScholarPubMed
Plotkin, S. A., Bechtel, D. J. & Sedwick, W. D. (1968). A simple method for removal of rubella hemagglutination-inhibitors from serum adaptable to finger-tip blood. American Journal of Epidemiology 88, 301–6.CrossRefGoogle ScholarPubMed
Purcell, R. H., Walsh, J. H., Holland, P. V., Morrow, A. G., Wood, S. & Chanock, R. M. (1971). Epidemiological studies of transfusion-associated hepatitis. Journal of Infectious Diseases 123, 406–13.CrossRefGoogle Scholar
Rifkind, D. (1966). The activation of varicella-zoster virus infections by immunosuppressive therapy. Journal of Laboratory and Clinical Medicine 68, 463–74.Google ScholarPubMed
Rowe, W. P., Hartley, J., Waterman, S., Turner, H. C. & Huebner, R. J. (1956). Cytopathogenic agent resembling human salivary gland virus recovered from the tissue cultures of human adenoids. Proceedings of the Society for Experimental Biology and Medicine 92, 418–24.Google ScholarPubMed
Rowley, M. J., Mackay, I. R. & McKenzie, I. F. C. (1969). Antibody production in immunosuppressed recipients of renal allografts. Lancet ii, 708–10.CrossRefGoogle Scholar
Starr, J. G., Calafiore, D. & Casey, H. L. (1967). Experience with a human cytomegalovirus complement-fixing antigen. American Journal of Epidemiology 86, 507–12.CrossRefGoogle ScholarPubMed
Stern, H. & Elek, S. D. (1965). The incidence of infection with cytomegalovirus in a normal population. Journal of Hygiene 63, 79–87.CrossRefGoogle Scholar
Stern, H., Lambert, H. P. & Shakespeare, W. G. (1963). Isolation of cytomegalovirus in an infant with an angiosarcoma. Archives of Disease in Childhood 38, 626–9.CrossRefGoogle Scholar
Stewart, G. L., Parkman, P. D., Hopps, H. E., Douglas, R. D., Hamilton, J. P. & Meyer, M. H. (1967). Rubella-virus hemagglutination-inhibition antibody test. New England Journal of Medicine 276, 554–7.CrossRefGoogle Scholar
Weller, T. H. (1970). Cytomegaloviruses: The difficult years. Journal of Infectious Diseases 122, 532–9.CrossRefGoogle ScholarPubMed
Weller, T. H., Hanshaw, J. B. & Scott, D. E. (1960). Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology 12, 130–2.CrossRefGoogle ScholarPubMed